Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential benefits. Preliminary findings suggest that this higher dosage may boost the drug's ability to control blood glucose, potentially offering more significant outcomes for individuals with type 2 diabetes. Further research is underway to fully explore th